Literature DB >> 11975983

A study on CD45 isoform expression during T-cell development and selection events in the human thymus.

Kenjiro Fukuhara1, Meinoshin Okumura, Hiroyuki Shiono, Masayoshi Inoue, Yoshihisa Kadota, Shinichiro Miyoshi, Hikaru Matsuda.   

Abstract

CD45 molecules are known to appear as various isoforms generated by alternative splicing of variable exons 4, 5, and 6, but the detailed profile of CD45 isoform expression during thymocyte development has not been revealed. We examined the CD45 isoforms expressed in the various human thymocytes' subsets defined by CD3, CD4, and CD8 expressions using RT-PCR and 4-color flow cytometry. RT-PCR study revealed that RABC, RAB, RBC, RB, and R0 isoforms were expressed in thymocytes while any of RAC, RA, or RC isoforms were not detected. RABC, RAB and RBC isoforms were expressed at CD3(-)CD4(-)CD8(-) and CD3(+)CD4(+)CD8(-) stages, but were barely detectable at CD3(-)CD4(+)CD8(+) stage. RB isoform was consistently expressed at a relatively high level at all stages. R0 isoform was expressed at a low level at CD3(-)CD4(-)CD8(-) and CD3(-)CD4(+)CD8(-) stages but upregulated at CD3(+)CD4(+)CD8(+) and CD3(+)CD4(+)CD8(-) stages. In combination with the results obtained by 4-color flow cytometric study, CD45 isoform expression on human thymocytes were determined to be RABC(+)RAB(+/-)RBC(+)RB(+)R0(+/-) at CD3(-)CD4(-)CD8(-) stage, RABC(-)RAB(-)RBC(-)RB(+)R0(+) at CD3(-)CD4(+)CD8(-) and CD3(-)CD4(+)CD8(+) stages, RABC(+/-)RAB(+)RBC(+)RB(++)R0(++) at CD3(+)CD4(+)CD8(+) stage, and RABC(+)RAB(+)RBC(+)RB(++)R0(+) at CD3(+)CD4(+)CD8(-) stage. Bcl-2 expression was upregulated between CD3(-)CD4(+)CD8(+)CD45R0(+) and CD3(+)CD4(+)CD8(+)CD45R0(+) stages. Expression of CD45R0 epitope was upregulated between CD3(-)CD4(+)CD8(+)CD69(-) and CD3(+)CD4(+)CD8(+)CD69(+) stages while CD45RA epitope expression was unchanged. Thus, when thymocytes are positively selected, CD45R0 isoform expression seems to be upregulated while CD45RABC isoform expression stays at a very low level. In summary, various isoforms of CD45 were shown to be tightly regulated during thymocyte development and through the selection process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11975983     DOI: 10.1016/s0198-8859(02)00379-8

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

Review 1.  T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival.

Authors:  Mary C Clark; Linda G Baum
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

2.  Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death.

Authors:  Mary C Clark; Mabel Pang; Daniel K Hsu; Fu-Tong Liu; Sven de Vos; Randy D Gascoyne; Jonathan Said; Linda G Baum
Journal:  Blood       Date:  2012-10-12       Impact factor: 22.113

3.  CD45RO enriches for activated, highly mutated human germinal center B cells.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jeffrey Zhang; Savannah Willson; Yoon J Kim; Christian Clanton; J Donald Capra
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

4.  The glycosylation status of murine [corrected] postnatal thymus: a study by histochemistry and lectin blotting.

Authors:  Erdal Balcan; Ayça Gümüş; Mesut Sahin
Journal:  J Mol Histol       Date:  2008-07-19       Impact factor: 2.611

5.  Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3.

Authors:  Geneviève de Saint Basile; Frédéric Geissmann; Elisabeth Flori; Béatrice Uring-Lambert; Claire Soudais; Marina Cavazzana-Calvo; Anne Durandy; Nada Jabado; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress.

Authors:  M C Gold; T Eid; S Smyk-Pearson; Y Eberling; G M Swarbrick; S M Langley; P R Streeter; D A Lewinsohn; D M Lewinsohn
Journal:  Mucosal Immunol       Date:  2012-06-13       Impact factor: 7.313

Review 7.  Alternative Splicing of Pre-mRNA in the Control of Immune Activity.

Authors:  Zhongjing Su; Dongyang Huang
Journal:  Genes (Basel)       Date:  2021-04-15       Impact factor: 4.096

Review 8.  The role played by alternative splicing in antigenic variability in human endo-parasites.

Authors:  Rodney Hull; Zodwa Dlamini
Journal:  Parasit Vectors       Date:  2014-01-28       Impact factor: 3.876

9.  Transcriptome profiling of human thymic CD4+ and CD8+ T cells compared to primary peripheral T cells.

Authors:  Hanna Helgeland; Ingvild Gabrielsen; Helle Akselsen; Arvind Y M Sundaram; Siri Tennebø Flåm; Benedicte Alexandra Lie
Journal:  BMC Genomics       Date:  2020-05-11       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.